ArticleThe Journal of biological chemistry2020

Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.

Joseph C Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.